Narrative review / 2013
Antioxidants and PUFAs show promising therapeutic potential for managing neuropsychiatric disorders, though excessive use carries risks.
This review examines oxidative stress in the pathophysiology of neuropsychiatric conditions such as schizophrenia, bipolar disorder, and major depression. Increased reactive oxygen species cause cellular damage to lipids, proteins, and DNA, leading to abnormal neural growth and differentiation. The authors report that supplementation with antioxidants and PUFAs has provided some promising results for long-term treatment management, though caution is warranted as excessive antioxidants may interfere with protective functions of reactive oxygen species.
- Study type
- Narrative review
- Who was studied
- Patients with neuropsychiatric disorders
- What was measured
- Therapeutic potential and outcomes of antioxidant and PUFA supplementation
THE PAPER
Antioxidants as potential therapeutics for neuropsychiatric disorders.
Pandya CD, Howell KR, Pillai A. Prog Neuropsychopharmacol Biol Psychiatry, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.